author-photo

Mark Heipel

Bristol-Myers Squibb

3

Papers

17

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models.

2013 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (10)